Anesket

Quick links to important sections

Anesket

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Anesket

What is Anesket? (Definitive Overview)

Property Description
Active ingredient Ketamine hydrochloride
Form Sterile solution for injection or infusion
Pharmacological class General Anesthetic / Dissociative Anesthetic
Common use Induction and maintenance of anesthesia for surgical procedures
Origin Fully synthetic cyclohexanone derivative

What Type of Medicine is Anesket?

Anesket is a trade name for a medicinal product based on the active compound Ketamine, which is formally categorized as a General Anesthetic. The substance is chemically defined as a synthetic cyclohexanone derivative. It belongs specifically to the class of dissociative anesthetics, which denotes its unique action of creating a functional "disconnection" within the central nervous system. This compound is highly regarded for its efficacy in acute care; it has been listed as an Essential Medicine since 1985. This status indicates the drug is necessary for a basic, functioning healthcare system.

Composition and General Purpose

The medication is supplied as a single active ingredient preparation, utilizing Ketamine hydrochloride, and is formulated as a clear, sterile aqueous solution for injection or infusion. This formulation is a racemic mixture, containing both the R- and S-enantiomers of the active substance. The primary purpose of Anesket is to facilitate surgical and diagnostic procedures by rapidly inducing a state of anesthesia.

Its mechanism as a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist is clinically recognized for creating this specific effect. This action ensures the patient achieves profound analgesia (pain relief) and amnesia (memory loss) during the intervention, which is essential for procedural efficacy and patient comfort.

Regulatory References

  1. WHO Essential Medicines List (Ketamine)
  2. Ketamine on WHO Essential Medicines List

What side effects are possible with Anesket?

Possible Side Effects and Safety Information

The safety profile of Anesket, which contains the active substance Ketamine, is formally documented by government regulatory authorities, detailing the potential adverse reactions and special considerations for use.

Adverse effects are categorized by frequency and the body system affected:

Classification System-Organ Class and Examples Frequency
Cardiovascular/Psychiatric Elevated blood pressure (Hypertension), increased heart rate (Tachycardia), emergence reactions (e.g., vivid dreams, confusion, delirium) Very Common
Neurological/Gastrointestinal Involuntary eye movement (Nystagmus), double vision (Diplopia), nausea, and vomiting Common
Respiratory Respiratory depression, temporary cessation of breathing (Apnea) Rare
Genitourinary/Hepatic Severe irritative urinary symptoms (Cystitis), abnormal liver function tests Not Known (Associated with chronic exposure)

Serious Adverse Reactions and Safety Constraints

The regulatory documents highlight the potential for severe respiratory depression and apnea, particularly if the medicine is administered too rapidly or in excessive amounts. Due to its effect on the circulatory system, Anesket is contraindicated in patients for whom a significant elevation of blood pressure or increased intracranial pressure (ICP) would constitute a serious hazard.

Safety notes tied to the duration of exposure are also documented. While cardiovascular changes and emergence reactions are typically transient, severe genitourinary symptoms and liver function abnormalities are primarily associated with a history of chronic or long-term high-dose exposure.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Anesket (Ketamine) is officially described in regulatory labeling as a condition resulting in potentially severe physiological effects across major body systems. The documented presentation of overdose includes profound central nervous system (CNS) depression, which may progress to stupor or coma. Exposure to overdosage, or a too rapid rate of administration, is noted to cause severe respiratory depression or apnea (cessation of breathing).

The cardiovascular system is also affected, with manifestations that include marked blood pressure elevation (hypertension) and increased heart rate (tachycardia). However, the potential for severe hypotension and cardiorespiratory arrest constitutes the most serious, life-threatening outcomes documented. Neurologically, prolonged and intense psychological effects, such as confusion and hallucinations, alongside enhanced skeletal muscle tone or movements resembling seizures, are also listed.

When to Seek Urgent Medical Help

Regulators explicitly state that a specific pharmacological antidote for Anesket overdose is not known, making management strictly reliant on symptomatic and supportive treatment. Immediate medical attention must be sought when any symptoms of overdose occur, especially if they involve loss of consciousness, dangerously slowed breathing, or cardiac irregularities. Official labeling mandates that supportive ventilation must be employed in cases of respiratory depression, and continuous monitoring of vital signs and cardiac function is required until complete clinical recovery is assured.

Therapeutic Uses of Anesket

What Anesket Treats — Main Uses and Benefits

Ketamine is a medication used across several key therapeutic areas to manage symptoms related to anesthesia, severe pain, and certain treatment-resistant mood disorders. It is applied across domains where additional symptomatic support is needed.

The medication is considered relevant in contexts involving heightened systemic burden. Its primary applications include supporting comfort and stability during necessary medical procedures, easing the burden of severe and acute pain symptoms, and providing supportive relief for challenging mental health symptoms.

Supporting Comfort and Stability During Medical Procedures

This domain covers the medication's primary role in rapidly inducing a state of deep sedation or unconsciousness. It is commonly used in acute settings when supportive symptom management is appropriate, assisting with maintaining functional stability and is applied in scenarios where additional management of discomfort is required, supporting patients during episodes of heightened discomfort.

Easing the Burden of Severe Symptoms

This includes managing the symptoms related to physical discomfort from trauma and providing supportive relief for severe depressive episodes. It helps address symptom clusters that may become intense or disruptive, contributing to easing the overall symptom load for the patient across conditions characterized by periods of heightened symptoms.


Quick Fact: Relief for Significant Discomfort

Regulatory References

  1. NIH MedlinePlus overview of Ketamine

Eligibility and Restrictions for Use

Regulatory documents explicitly define which populations are eligible to use Anesket (ketamine) and which are strictly contraindicated, or prohibited from use.

Populations That Must Not Use Anesket (Contraindicated)

The medicine is formally contraindicated and must not be used in:

  • Hypersensitivity: Patients with a known allergy or hypersensitivity to ketamine or any of the non-medicinal ingredients/excipients in the formulation.
  • Severe Cardiovascular Risk: Patients for whom a significant elevation of blood pressure or heart rate would constitute a serious hazard. This exclusion includes individuals with severe or poorly controlled hypertension, severe cardiac decompensation (such as congestive heart failure), or known cerebrovascular disease.

Eligibility-Related Restrictions

The drug is allowed for use in the indicated population, but regulatory agencies require caution or special consideration for specific patient groups:

  • Pediatric Use: Safety and effectiveness have not been formally established in patients below the age of 16 years.
  • Pre-Existing Conditions: Caution is advised for patients with elevated intracranial pressure (e.g., from head injury), intraocular pressure (e.g., glaucoma), hepatic impairment, or those with a history of psychiatric illness (e.g., schizophrenia or acute psychosis).

What should I know about interactions with other medicines?

Official Interaction Statements

The regulatory profile for Anesket (Ketamine) details interaction patterns primarily classified as pharmacodynamic or pharmacokinetic, based on outcomes documented in official labeling.

Category Documented Interaction Outcome
CNS Pharmacodynamic Co-administration with CNS depressants (e.g., opioid analgesics, benzodiazepines) or alcohol may result in additive effects, including profound sedation, respiratory depression, coma, and death. Opioids may also prolong the time to full recovery.
Cardiovascular/Sympathomimetic Concomitant use with thyroid hormones or sympathomimetics (including Vasopressin) may enhance the sympathomimetic effects of Anesket, leading to increased risk of hypertension and tachycardia.
Metabolic (Pharmacokinetic) Co-administration with medicines that inhibit CYP3A4 may increase Anesket's plasma concentrations (exposure), while inducers of CYP3A4 may decrease exposure.

Interaction-Related Restrictions and Considerations

Official documents advise against co-administering Anesket with Theophylline or Aminophylline due to the potential for lowering the seizure threshold. Furthermore, patients with hepatic impairment are noted to have a potential for increased severity or duration of effects/interactions due to the drug's primary hepatic metabolism.

Mechanism of Action

NMDAR Blockade and Excitatory System Modulation

Anesket acts as a noncompetitive antagonist at the N-methyl-D-aspartate receptor (NMDAR) channel, limiting ion flux and modulating the central signal transmission driven by the excitatory neurotransmitter, glutamate. . This mechanistic blockade results in a state of dissociative consciousness and modulates pain signaling pathways, influencing the communication and transmission of neural signals within the central nervous system (CNS).


Secondary System Interactions and Physiological Refinement

The mechanistic activity is supplemented by secondary interactions, including weak agonism at opioid receptors and inhibition of HCN1 channels. These interactions modulate pain signaling and neuronal excitability, influencing the overall physiological outcome and the alterations in perception and cognitive function.


Sympathetic Activation and Cardiovascular Consequences

Anesket’s mechanism indirectly stimulates the sympathetic nervous system, increasing the availability of central and peripheral catecholamines. This mechanistic cascade results in the observable physiological consequence of maintaining or increasing heart rate and blood pressure, reflecting increased sympathetic output during the period of activity.

Dosage and Administration Information

Anesket (Ketamine) is provided as a sterile aqueous solution and is indicated for parenteral administration in the induction and maintenance of anesthesia. The primary routes of administration are Intravenous (IV) injection or infusion and Intramuscular (IM) injection.

Dosing is always weight-based and calculated in milligrams per kilogram (mg/kg). For IV induction, the usual starting dose ranges from 1 mg/kg to 4.5 mg/kg. The dose for IM induction is typically higher, ranging from 6.5 mg/kg to 13 mg/kg. Dose selection should be cautious, starting at the low end of the dosing range, for populations such as older adults and individuals with hepatic impairment.

Specific preparation and timing instructions are mandated. The high-concentration 100 mg/mL vial must be diluted with a compatible solution (e.g., 0.9% Sodium Chloride) before IV use. The IV injection must be administered slowly over a period of 60 seconds to adhere to standard administration protocols.

Since the effect of a single induction dose is short-lived (typically 5 to 25 minutes), anesthesia is maintained by administering intermittent re-dosing (half to full initial dose) as needed, or by initiating a continuous IV infusion at specified rates. Administration is restricted to being under the supervision of physicians experienced in general anesthetics.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Anesket


Evidence for Use in Anesthesia and Procedural Sedation

Anesket (ketamine's active ingredient) was studied for the induction and maintenance of general anesthesia over several decades. Researchers conducted a high volume of controlled trials, including comparisons with other anesthetic medications, to examine its use during surgical and diagnostic procedures. Studies primarily monitored outcomes related to the speed of achieving an anesthetic state, the need for any supplemental anesthetic medications during the procedure, and outcomes monitoring physiological strain or stress, such as heart rate and blood pressure, during the intervention.

In these research contexts, the findings describe patterns observed in the studies related to the rapid onset of the anesthetic state. Research also describes how the medication was observed in studies regarding outcomes monitoring physiological strain or stress, particularly in patients with pre-existing conditions. Because this use is long-established, the evidence base is extensive.


Evidence for Use in Acute Pain Management

Research has explored the use of Anesket as an additional treatment in situations involving acute, severe physical discomfort, such as following surgery or major trauma. The studies conducted were evaluated in placebo-controlled trials and comparisons with conventional opioid pain medications. Trials reported measurements of pain intensity changes in the observed populations, and some findings were associated with the drug's use. Research also described patterns where the overall amount of opioid medication monitored in patients receiving the drug was observed to differ from control groups, which contributes to understanding patient-reported outcomes describing perceived discomfort.

However, follow-up durations were limited in many studies. Research exploring short-term symptom changes is robust, but the long-term outcomes reflecting daily functioning or activity level are areas where evidence is limited.


Research on Treatment-Resistant Depression

The use of Anesket's active ingredient was studied for its relevance in trials assessing short-term or episodic symptom patterns in conditions characterized by severe, treatment-resistant mood disorders. Studies examined symptom intensity or variability using standardized clinical scales and monitored outcomes capturing phases of heightened symptom activity.

Findings from these trials describe patterns observed in the studies related to changes measured in depression severity scores, often within hours of administration. Research highlights that these changes, when observed, appear to be temporary, and some trials explored whether repeated administrations was associated with sustained measurements. Long-term effects are not fully established regarding the durability of these patterns, and data are still emerging.

Key Studies & References

  1. Ketamine - StatPearls - NCBI Bookshelf (NIH)
  2. The Impact of Ketamine on Outcomes in Acute Pain Management: An Umbrella Review
  3. WHO Model List of Essential Medicines - Ketamine

Frequently Asked Questions (FAQ)

Common questions about Anesket (FAQ)

Q: How quickly does Anesket start working for pain or procedures?

A: Anesket works very quickly. According to official product information, when the drug is administered intravenously (IV), it typically produces a state of anesthesia within approximately 30 seconds.

Q: What happens in the brain when someone is given Anesket?

A: Anesket causes a state known as 'dissociative anesthesia.' This involves a functional separation within the nervous system, mainly between the parts of the brain that handle sensation and emotion. This unique mechanism results in both profound analgesia (pain relief) and amnesia (memory loss) during the procedure.

Q: Are there any widely reported 'weird' or unusual side effects with Anesket?

A: Yes, 'Emergence reactions' are a very common and well-documented side effect of Anesket. These reactions occur as the patient wakes up and can include experiencing vivid dreams, confusion, or a temporary state of delirium. Patients are monitored by healthcare professionals during the recovery period.

Q: What is the feeling like when Anesket is taking effect?

A: Because Anesket is a 'dissociative anesthetic,' it creates a unique state of consciousness. Patients may report feelings of detachment from their body and surroundings. It can also lead to altered perceptions, such as experiencing vivid dreams or hallucinations as the drug takes effect or wears off.

Q: Is it normal to feel a bit confused or dizzy after Anesket wears off?

A: Yes, feeling confused or dizzy during the recovery phase is a documented side effect. The confusion is considered part of the 'emergence reactions' that can last throughout the recovery period as the effects of the anesthesia fade.

Q: Can Anesket be used safely in children for certain procedures?

A: Anesket is approved for the induction of anesthesia and is used in both adult and pediatric populations. However, regulatory documents state that safety and effectiveness have not been formally established in patients below the age of 16 years for all possible uses, therefore, special considerations are necessary during its use in this group.

Q: Is Anesket ever given to older adults, and are there different risks?

A: Anesket may be administered to older adults, but regulatory information advises extra caution. Official prescribing information notes that dose selection must be cautious and generally starts at the low end of the dosing range, due to the increased possibility of age-related conditions affecting the heart, liver, or kidneys.

Q: Can Anesket be given if a patient is already taking antidepressants?

A: Certain types of antidepressants, specifically Monoamine Oxidase Inhibitors (MAOIs), are contraindicated (prohibited) with Anesket due to the risk of dangerous increases in blood pressure. It is important that healthcare providers are aware of all medications being taken, as other types of antidepressants may require review for potential drug interactions.

Q: What does the term 'emergence reaction' mean when talking about Anesket?

A: An emergence reaction is a very common side effect that may occur as a patient recovers from anesthesia. It refers to temporary neurological symptoms such as acute confusion, agitation, excitement, or a temporary state of delirium and vivid dreams.

Q: Why does Anesket sometimes cause vivid dreams or hallucinations?

A: Official information suggests this is linked to the drug's primary mechanism of action as a dissociative anesthetic. By creating a functional disconnection in the brain's pathways, the drug can cause these altered perceptions, including vivid dreams and hallucinations, especially as the patient is waking up.

Q: Is the sensation of feeling detached from one's body (dissociation) normal with Anesket?

A: Yes, Anesket is classified as a 'dissociative anesthetic,' which means the characteristic effect involves creating a feeling of detachment or functional disconnection within the nervous system. This sensation is expected as the drug is working.

Q: Is Anesket a controlled substance, and what does that mean?

A: Yes, the active ingredient in Anesket, Ketamine, is classified as a Schedule III non-narcotic controlled substance in the United States. This classification means it has an accepted medical use but also carries a moderate to low potential for physical and psychological dependence or misuse.

Q: Do patients typically wake up easily after a procedure involving Anesket?

A: Recovery is generally described as rapid. Awakening may be associated with emergence reactions, which can include temporary confusion or excitement. Patients are typically monitored by healthcare staff until they return to their baseline level of awareness.

Q: Is Anesket something that is usually given as a shot or through an IV?

A: Anesket is strictly approved for parenteral administration, meaning it is given by injection or infusion. The two primary approved methods are Intravenous (IV) injection or infusion and Intramuscular (IM) injection. The medical team will choose the specific route based on the procedure and patient needs.

Q: How common is nausea or vomiting after being given Anesket?

A: Nausea and vomiting are documented as Common side effects of Anesket. These effects are typically managed as part of the overall post-procedure care.

Q: Are there different forms of Anesket, like a nasal spray or oral tablet?

A: The official formulation of Anesket (Ketamine) is approved as a clear, sterile aqueous solution for injection or infusion only. While other forms of ketamine-based products exist, this specific product is intended only for administration by injection or IV.

Q: Does Anesket have any effects on blood pressure?

A: Yes, Anesket can cause a significant elevation of blood pressure and an increased heart rate. Due to this effect on the circulatory system, regulatory documents state that the drug must not be used in patients for whom this elevation would pose a serious medical risk.

Q: Can Anesket be used in patients who have liver or kidney problems?

A: Caution is specifically advised for patients who have hepatic (liver) impairment. Furthermore, the official documents state that severe genitourinary symptoms (such as cystitis) have been associated with chronic or long-term high-dose exposure, which may affect the bladder and kidneys.

Q: Are there specific monitoring requirements for patients receiving Anesket?

A: Yes, Anesket must only be administered under the supervision of physicians experienced in general anesthetics. Official safety documents state that patients must be closely monitored, with attention paid to vital signs like heart rate, blood pressure, oxygen levels, and the level of consciousness.

Q: Does the body build up a tolerance to Anesket over time?

A: Official information indicates that Anesket has the potential for abuse and dependence. When a patient uses any Schedule III substance over a prolonged period, the impact may diminish, which is consistent with the body building up a tolerance to the drug’s effects.

Q: What is the history of Anesket's development and use?

A: The active ingredient in Anesket, Ketamine, was developed in the early 1960s and received formal approval from the FDA in 1970. The drug's importance to healthcare systems is recognized globally, and it has been listed by the World Health Organization (WHO) as an Essential Medicine since 1985.

Q: Does Anesket have any effects on muscle relaxation during a procedure?

A: The official product information notes that Anesket is suitable for procedures that do not require skeletal muscle relaxation and that it can, in fact, cause enhanced skeletal muscle tone. It is not classified as a muscle relaxant.

How should Anesket be stored and disposed of?

How to Store and Dispose of Anesket

Official regulatory guidelines dictate strict handling and storage rules for Anesket (ketamine hydrochloride injection) to maintain its integrity and ensure compliance as a controlled substance.

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, between 20 C to 25 C (68 F to 77 F).
Environmental Must be protected from light and not frozen.
Security Keep out of the sight and reach of children and store securely (often locked up).
Packaging Store in the original container to maintain protection.

Disposal Instructions

Disposal of unused or expired Anesket must comply with local, state, and federal regulations. The product should not be disposed of in wastewater. The preferred method is returning the medication through an authorized drug take-back program. If this is unavailable, the drug must be mixed with an undesirable substance, sealed, and discarded in the household trash, according to FDA guidelines for controlled substances.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Anesket found in:

A-Z Index: